Radiation oncology firm Elekta of Stockholm, Sweden, has signed a letter of intent to acquire radiation treatment planning firm CMS of St. Louis for $75 million.
Elekta plans to finalize negotiations by mid-February and close the transaction in March. The acquisition remains subject to regulatory approvals and other conditions.
The deal would add CMS' radiation treatment planning (RTP) systems, as well as its Mosaiq information management product, to Elekta's oncology portfolio.
CMS has 290 employees worldwide, with regional offices in Tampa, FL; Freiburg, Germany; Tokyo; Sydney, Australia; and Shanghai. In fiscal year 2007 (end-September 30), the company reported orders valuing $61 million.
In October, CMS received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Monaco, a next-generation intensity-modulated radiation therapy (IMRT) planning platform.
Related Reading
CMS nets FDA OK for Monaco, October 16, 2007
Elekta to introduce new VMAT at ASTRO show, October 18, 2007
Elekta MEG system in new U.K. facility, October 12, 2007
Elekta receives Austrian contract, September 28, 2007
Elekta receives Italian orders, September 25, 2007
Copyright © 2008 AuntMinnie.com
